These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 38233485)

  • 1. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis.
    Kuraji R; Ye C; Zhao C; Gao L; Martinez A; Miyashita Y; Radaic A; Kamarajan P; Le C; Zhan L; Range H; Sunohara M; Numabe Y; Kapila YL
    NPJ Biofilms Microbiomes; 2024 Jan; 10(1):3. PubMed ID: 38233485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nisin probiotic prevents inflammatory bone loss while promoting reparative proliferation and a healthy microbiome.
    Gao L; Kuraji R; Zhang MJ; Martinez A; Radaic A; Kamarajan P; Le C; Zhan L; Ye C; Rangé H; Sailani MR; Kapila YL
    NPJ Biofilms Microbiomes; 2022 Jun; 8(1):45. PubMed ID: 35672331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
    Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
    World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nisin a probiotic bacteriocin mitigates brain microbiome dysbiosis and Alzheimer's disease-like neuroinflammation triggered by periodontal disease.
    Zhao C; Kuraji R; Ye C; Gao L; Radaic A; Kamarajan P; Taketani Y; Kapila YL
    J Neuroinflammation; 2023 Oct; 20(1):228. PubMed ID: 37803465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of
    Wang T; Ishikawa T; Sasaki M; Chiba T
    Front Med (Lausanne); 2022; 9():822190. PubMed ID: 35308549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.
    Kuraji R; Sekino S; Kapila Y; Numabe Y
    Periodontol 2000; 2021 Oct; 87(1):204-240. PubMed ID: 34463983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis of the Subgingival Microbiome and Relation to Periodontal Disease in Association with Obesity and Overweight.
    Rahman B; Al-Marzooq F; Saad H; Benzina D; Al Kawas S
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymicrobial periodontal disease triggers a wide radius of effect and unique virome.
    Gao L; Kang M; Zhang MJ; Reza Sailani M; Kuraji R; Martinez A; Ye C; Kamarajan P; Le C; Zhan L; Rangé H; Ho SP; Kapila YL
    NPJ Biofilms Microbiomes; 2020 Mar; 6(1):10. PubMed ID: 32157085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
    Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet-Induced Non-alcoholic Fatty Liver Disease and Associated Gut Dysbiosis Are Exacerbated by Oral Infection.
    Simas AM; Kramer CD; Genco CA
    Front Oral Health; 2021; 2():784448. PubMed ID: 35141703
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Gasmi Benahmed A; Kumar Mujawdiya P; Noor S; Gasmi A
    Arch Razi Inst; 2022 Oct; 77(5):1539-1551. PubMed ID: 37123122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Xie C; Halegoua-DeMarzio D
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral infection with a periodontal pathogen alters oral and gut microbiomes.
    Simas AM; Kramer CD; Weinberg EO; Genco CA
    Anaerobe; 2021 Oct; 71():102399. PubMed ID: 34090994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymicrobial infection with major periodontal pathogens induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null) mice.
    Rivera MF; Lee JY; Aneja M; Goswami V; Liu L; Velsko IM; Chukkapalli SS; Bhattacharyya I; Chen H; Lucas AR; Kesavalu LN
    PLoS One; 2013; 8(2):e57178. PubMed ID: 23451182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease.
    Kesavalu L; Sathishkumar S; Bakthavatchalu V; Matthews C; Dawson D; Steffen M; Ebersole JL
    Infect Immun; 2007 Apr; 75(4):1704-12. PubMed ID: 17210663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global TLR2 and 4 deficiency in mice impacts bone resorption, inflammatory markers and atherosclerosis to polymicrobial infection.
    Chukkapalli SS; Velsko IM; Rivera-Kweh MF; Larjava H; Lucas AR; Kesavalu L
    Mol Oral Microbiol; 2017 Jun; 32(3):211-225. PubMed ID: 27224005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The oral microbiome in the context of systemic disease].
    Leonov GE; Varaeva YR; Livantsova EN; Starodubova AV
    Vopr Pitan; 2023; 92(4):6-19. PubMed ID: 37801450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Oral Care Chip, a novel device for quantitative detection of the oral microbiota associated with periodontal disease.
    Nozawa A; Oshima H; Togawa N; Nozaki T; Murakami S
    PLoS One; 2020; 15(2):e0229485. PubMed ID: 32109938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.